The Scan

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

CNBC reports that the CDC Director says a SARS-CoV-2 vaccine isn't likely to be generally available until the third quarter of 2021, timing President Donald Trump disputes.

In Nature this week: MassIVE.quant resource houses mass spectrometry-based proteomic data, influence of Viking genetics on European populations, and more.

Technology Review reports synthetic biologists are developing an attenuated SARS-CoV-2 to use in a vaccine.

In Genome Biology this week: improved reference genome for the Asian tiger mosquito Aedes albopictus, links between Ebola variants and outcomes, and more.

According to the Los Angeles Times, National Institutes of Health officials are concerned about the possible side effect reported by a COVID-19 vaccine trial.

In PNAS this week: modeling of Rift Valley Fever spillover, Asian mosquito could pose malaria threat, and more.

Politico reports that political appointees are interfering with what appears in the Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Reports.

In PLOS this week: functional effect of adiponectin-linked variants, sequencing reveals regional differences among Swedes, and more.

Court documents suggest Theranos' Elizabeth Holmes' defense team might rely on "expert evidence relating to a mental disease or defect," CNN reports.

In Science this week: additional variants linked to development of primary lymphedema, and more.